These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23169061)

  • 1. Melanocytes--a novel tool to study mitochondrial dysfunction in Duchenne muscular dystrophy.
    Pellegrini C; Zulian A; Gualandi F; Manzati E; Merlini L; Michelini ME; Benassi L; Marmiroli S; Ferlini A; Sabatelli P; Bernardi P; Maraldi NM
    J Cell Physiol; 2013 Jun; 228(6):1323-31. PubMed ID: 23169061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin cells for use in an alternate diagnostic method for Duchenne muscular dystrophy.
    Tyers L; Davids LM; Wilmshurst JM; Esterhuizen AI
    Neuromuscul Disord; 2018 Jul; 28(7):553-563. PubMed ID: 29958823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies.
    Janghra N; Morgan JE; Sewry CA; Wilson FX; Davies KE; Muntoni F; Tinsley J
    PLoS One; 2016; 11(3):e0150818. PubMed ID: 26974331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric Cell Therapy Transfers Healthy Donor Mitochondria in Duchenne Muscular Dystrophy.
    Siemionow M; Bocian K; Bozyk KT; Ziemiecka A; Siemionow K
    Stem Cell Rev Rep; 2024 Oct; 20(7):1819-1829. PubMed ID: 39017908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic utility of skin biopsy in dystrophinopathies.
    Tanveer N; Sharma MC; Sarkar C; Gulati S; Kalra V; Singh S; Bhatia R
    Clin Neurol Neurosurg; 2009 Jul; 111(6):496-502. PubMed ID: 19251360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation in dystrophin-encoding gene affects energy metabolism in mouse myoblasts.
    Onopiuk M; Brutkowski W; Wierzbicka K; Wojciechowska S; Szczepanowska J; Fronk J; Lochmüller H; Górecki DC; Zabłocki K
    Biochem Biophys Res Commun; 2009 Aug; 386(3):463-6. PubMed ID: 19527684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duchenne muscular dystrophy cell culture models created by CRISPR/Cas9 gene editing and their application in drug screening.
    Soblechero-Martín P; Albiasu-Arteta E; Anton-Martinez A; de la Puente-Ovejero L; Garcia-Jimenez I; González-Iglesias G; Larrañaga-Aiestaran I; López-Martínez A; Poyatos-García J; Ruiz-Del-Yerro E; Gonzalez F; Arechavala-Gomeza V
    Sci Rep; 2021 Sep; 11(1):18188. PubMed ID: 34521928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal Muscle Differentiation on a Chip Shows Human Donor Mesoangioblasts' Efficiency in Restoring Dystrophin in a Duchenne Muscular Dystrophy Model.
    Serena E; Zatti S; Zoso A; Lo Verso F; Tedesco FS; Cossu G; Elvassore N
    Stem Cells Transl Med; 2016 Dec; 5(12):1676-1683. PubMed ID: 27502519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
    Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
    J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naturally occurring utrophin correlates with disease severity in Duchenne muscular dystrophy.
    Kleopa KA; Drousiotou A; Mavrikiou E; Ormiston A; Kyriakides T
    Hum Mol Genet; 2006 May; 15(10):1623-8. PubMed ID: 16595608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we?
    Miura P; Jasmin BJ
    Trends Mol Med; 2006 Mar; 12(3):122-9. PubMed ID: 16443393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Deflazacort Treatment on the Functioning of Skeletal Muscle Mitochondria in Duchenne Muscular Dystrophy.
    Dubinin MV; Talanov EY; Tenkov KS; Starinets VS; Belosludtseva NV; Belosludtsev KN
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative utrophin mRNAs contribute to phenotypic differences between dystrophin-deficient mice and Duchenne muscular dystrophy.
    Perkins KJ; Davies KE
    FEBS Lett; 2018 Jun; 592(11):1856-1869. PubMed ID: 29772070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional and epigenetic analyses of the DMD locus reveal novel cis‑acting DNA elements that govern muscle dystrophin expression.
    Gherardi S; Bovolenta M; Passarelli C; Falzarano MS; Pigini P; Scotton C; Neri M; Armaroli A; Osman H; Selvatici R; Gualandi F; Recchia A; Mora M; Bernasconi P; Maggi L; Morandi L; Ferlini A; Perini G
    Biochim Biophys Acta Gene Regul Mech; 2017 Nov; 1860(11):1138-1147. PubMed ID: 28867298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel canine model for Duchenne muscular dystrophy (DMD): single nucleotide deletion in DMD gene exon 20.
    Mata López S; Hammond JJ; Rigsby MB; Balog-Alvarez CJ; Kornegay JN; Nghiem PP
    Skelet Muscle; 2018 May; 8(1):16. PubMed ID: 29843823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: implication for clinical trials.
    Arechavala-Gomeza V; Kinali M; Feng L; Guglieri M; Edge G; Main M; Hunt D; Lehovsky J; Straub V; Bushby K; Sewry CA; Morgan JE; Muntoni F
    Neuromuscul Disord; 2010 May; 20(5):295-301. PubMed ID: 20395141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of brain utrophin does not rescue behavioral alterations in dystrophin-deficient mice.
    Perronnet C; Chagneau C; Le Blanc P; Samson-Desvignes N; Mornet D; Laroche S; De La Porte S; Vaillend C
    Hum Mol Genet; 2012 May; 21(10):2263-76. PubMed ID: 22343141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duchenne and Becker muscular dystrophy: a molecular and immunohistochemical approach.
    Freund AA; Scola RH; Arndt RC; Lorenzoni PJ; Kay CK; Werneck LC
    Arq Neuropsiquiatr; 2007 Mar; 65(1):73-6. PubMed ID: 17420831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Creation of Dystrophin Expressing Chimeric Cells of Myoblast Origin as a Novel Stem Cell Based Therapy for Duchenne Muscular Dystrophy.
    Siemionow M; Cwykiel J; Heydemann A; Garcia-Martinez J; Siemionow K; Szilagyi E
    Stem Cell Rev Rep; 2018 Apr; 14(2):189-199. PubMed ID: 29305755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.